- SPACs
- Leader’s Advantage Acquisition Corp.
Leader’s Advantage Acquisition Corp.
Searching since IPO 2026-09-21- CIK 2109823
- LEDR
- IPO 2026-09-21
- $151M trust
- 24 filings
- IPO Size
- $150M
- raised at the IPO
- Trust Amount
- $151M
- held for shareholders
- Current Status
- IPO
- from its latest filing
- IPO Year
- 2026
- year it listed
Filings, by quarter
24 filings over 3 quarters; violet bars carry a milestone
- 26 Q2: 2 filings
- 26 Q3: 21 filings
- 26 Q4: 1 filing
- S-1 filed 26 Q2
- IPO 26 Q3
SPAC Overview
Where it stands on the road from S-1 to merger
Timeline Progress
- Registration2026-04-29 Filed S1
- IPO2026-09-21 IPO, search begins
- Definitive AgreementNo merger agreement yet
- CompletedNot yet completed
About
Leader’s Advantage Acquisition Corp. is a blank-check company formed to effect a business combination with an unidentified business. It intends to focus on established businesses of scale in healthcare, specialty chemicals, pharmaceutical, and defense industries.
Investment Focus
Healthcare, Specialty Chemicals, Biopharmaceuticals, Defense
Key Information
As the filings state it
- IPO Date
- 2026-09-21
- Jurisdiction of Incorporation
- Cayman Islands
- SIC
- 6770
- SPAC Ticker
- LEDR
Stock Performance
LEDRUTrading symbol, and its price at each step since the first trade
| Point | Date | Price | Move |
|---|---|---|---|
| First Trade | 2026-09-21 | $9.97 | |
| Current Price | 2026-10-23 | $9.96 | -0% |
SPAC Team
The banks on its IPO, and the team as the filings describe it
Underwriters
Extended Team Information
Led by Dr. Paritosh M. Chakrabarti, Dr. Raj Chakrabarti, and Edward Krynski, the team describes experience building and managing chemical, pharmaceutical, and healthcare businesses, biotech and drug discovery operations, acquisitions, and corporate finance.